Natural history of low-grade squamous intraepithelial lesion

H. S. Saw, Jae Kwan Lee, H. L. Lee, H. J. Jee, Jong Jin Hyun

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective. To determine guidelines for management of CIN1 by evaluating its natural history. Methods. One hundred fifty-eight patients were diagnosed with CIN1 had colposcopy follow-up with or without cytology every three months. Results. Colposcopically directed biopsy confirmed progression to CIN2 or CIN3 in 17 of 158 (10.7%) patients, persistence of CIN1 in 87 (55%) patients, regression to normal in 54 (34.2%) patients during the 5-year follow-up period. The percentage of abnormal Pap tests were 39%, 64%, and 71% in the regression, persistent, and progression groups, respectively. The percentage of HPV-positive tests were 16%, 29%, 65% in regression, persistent, and progression groups, respectively. Conclusions. Of the patients who were diagnosed with CIN1 and monitored by colposcopy for 60 months, 34% had disease regression, 55% had persistent disease, and 11% had progressive disease. HPV DNA testing is more informative than the Pap test in the prediction of disease progression.

Original languageEnglish
Pages (from-to)153-158
Number of pages6
JournalJournal of Lower Genital Tract Disease
Volume5
Issue number3
DOIs
Publication statusPublished - 2001 Dec 27

Fingerprint

Papanicolaou Test
Colposcopy
Natural History
Cell Biology
Disease Progression
Squamous Intraepithelial Lesions of the Cervix
Guidelines
Biopsy
DNA

Keywords

  • HPV DNA test
  • LGSIL
  • Natural history

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Cite this

Natural history of low-grade squamous intraepithelial lesion. / Saw, H. S.; Lee, Jae Kwan; Lee, H. L.; Jee, H. J.; Hyun, Jong Jin.

In: Journal of Lower Genital Tract Disease, Vol. 5, No. 3, 27.12.2001, p. 153-158.

Research output: Contribution to journalArticle

@article{7b382dc91e224327a3f21677020b2b2d,
title = "Natural history of low-grade squamous intraepithelial lesion",
abstract = "Objective. To determine guidelines for management of CIN1 by evaluating its natural history. Methods. One hundred fifty-eight patients were diagnosed with CIN1 had colposcopy follow-up with or without cytology every three months. Results. Colposcopically directed biopsy confirmed progression to CIN2 or CIN3 in 17 of 158 (10.7{\%}) patients, persistence of CIN1 in 87 (55{\%}) patients, regression to normal in 54 (34.2{\%}) patients during the 5-year follow-up period. The percentage of abnormal Pap tests were 39{\%}, 64{\%}, and 71{\%} in the regression, persistent, and progression groups, respectively. The percentage of HPV-positive tests were 16{\%}, 29{\%}, 65{\%} in regression, persistent, and progression groups, respectively. Conclusions. Of the patients who were diagnosed with CIN1 and monitored by colposcopy for 60 months, 34{\%} had disease regression, 55{\%} had persistent disease, and 11{\%} had progressive disease. HPV DNA testing is more informative than the Pap test in the prediction of disease progression.",
keywords = "HPV DNA test, LGSIL, Natural history",
author = "Saw, {H. S.} and Lee, {Jae Kwan} and Lee, {H. L.} and Jee, {H. J.} and Hyun, {Jong Jin}",
year = "2001",
month = "12",
day = "27",
doi = "10.1046/j.1526-0976.2001.53007.x",
language = "English",
volume = "5",
pages = "153--158",
journal = "Journal of Lower Genital Tract Disease",
issn = "1089-2591",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Natural history of low-grade squamous intraepithelial lesion

AU - Saw, H. S.

AU - Lee, Jae Kwan

AU - Lee, H. L.

AU - Jee, H. J.

AU - Hyun, Jong Jin

PY - 2001/12/27

Y1 - 2001/12/27

N2 - Objective. To determine guidelines for management of CIN1 by evaluating its natural history. Methods. One hundred fifty-eight patients were diagnosed with CIN1 had colposcopy follow-up with or without cytology every three months. Results. Colposcopically directed biopsy confirmed progression to CIN2 or CIN3 in 17 of 158 (10.7%) patients, persistence of CIN1 in 87 (55%) patients, regression to normal in 54 (34.2%) patients during the 5-year follow-up period. The percentage of abnormal Pap tests were 39%, 64%, and 71% in the regression, persistent, and progression groups, respectively. The percentage of HPV-positive tests were 16%, 29%, 65% in regression, persistent, and progression groups, respectively. Conclusions. Of the patients who were diagnosed with CIN1 and monitored by colposcopy for 60 months, 34% had disease regression, 55% had persistent disease, and 11% had progressive disease. HPV DNA testing is more informative than the Pap test in the prediction of disease progression.

AB - Objective. To determine guidelines for management of CIN1 by evaluating its natural history. Methods. One hundred fifty-eight patients were diagnosed with CIN1 had colposcopy follow-up with or without cytology every three months. Results. Colposcopically directed biopsy confirmed progression to CIN2 or CIN3 in 17 of 158 (10.7%) patients, persistence of CIN1 in 87 (55%) patients, regression to normal in 54 (34.2%) patients during the 5-year follow-up period. The percentage of abnormal Pap tests were 39%, 64%, and 71% in the regression, persistent, and progression groups, respectively. The percentage of HPV-positive tests were 16%, 29%, 65% in regression, persistent, and progression groups, respectively. Conclusions. Of the patients who were diagnosed with CIN1 and monitored by colposcopy for 60 months, 34% had disease regression, 55% had persistent disease, and 11% had progressive disease. HPV DNA testing is more informative than the Pap test in the prediction of disease progression.

KW - HPV DNA test

KW - LGSIL

KW - Natural history

UR - http://www.scopus.com/inward/record.url?scp=0035214861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035214861&partnerID=8YFLogxK

U2 - 10.1046/j.1526-0976.2001.53007.x

DO - 10.1046/j.1526-0976.2001.53007.x

M3 - Article

VL - 5

SP - 153

EP - 158

JO - Journal of Lower Genital Tract Disease

JF - Journal of Lower Genital Tract Disease

SN - 1089-2591

IS - 3

ER -